Malaria Pf/Pv Antigen Rapid Test

The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.

The Malaria P.f/Pan Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium species (Pan) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.

RSV Antigen Rapid Test

The RSV antigen rapid test is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute RSV virus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.

LH Rapid Quantitative Test

Luteinizing hormone is a hormone produced by gonadotropic cells in the anterior pituitary gland. In females, an acute rise of LH ("LH surge") triggers ovulation and development of the corpus luteum. In males, where LH had also been called interstitial cell‒stimulating hormone (ICSH), it stimulates Leydig cell production of testosterone. It acts synergistically with follicle-stimulating hormone (FSH).

SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Rubella IgG/IgM Rapid Test (Fluorescence Immunoassay)

TheRubella IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toRubella in human serum.IgG results with this assay are used to indicate past or recent infection withRubella. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recent Rubella infections. Rubella IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy.

Myo Rapid Quantitative Test

Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.

CRP Rapid Quantitative Test

The C-reactive protein(CRP) is synthesized by the liver in response to interleukin-6 and is well known as one of the classical acute-phase reactants. It is used as a marker of inflammation and cardiovascular diseases(C-VD). Biotime CRP test includes hs-CRP and normal CRP test parameters which has wider test range.

β-HCG Rapid Quantitative Test

β-HCG is a fluorescent immunoassay for the quantitative measurement of β-HCG level in human serum and whole blood. This test is performed to help diagnose pregnancy if a woman is to undergo a medical treatment, be placed on certain drugs, or have other testing, such as x-rays, that might harm the developing baby.